Xponance Inc. Has $9.79 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Xponance Inc. increased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,469 shares of the biotechnology company's stock after buying an additional 560 shares during the quarter. Xponance Inc.'s holdings in Axon Enterprise were worth $9,788,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the 4th quarter worth $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise during the 4th quarter worth $45,000. Prestige Wealth Management Group LLC grew its stake in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares during the last quarter. Stonebridge Financial Group LLC bought a new position in Axon Enterprise during the 4th quarter worth $53,000. Finally, GPS Wealth Strategies Group LLC grew its stake in Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after buying an additional 40 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Performance

Shares of AXON stock traded up $1.59 during mid-day trading on Friday, reaching $560.00. The stock had a trading volume of 802,214 shares, compared to its average volume of 845,276. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm has a market cap of $42.91 billion, a PE ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $715.99. The firm's 50 day simple moving average is $591.90 and its 200 day simple moving average is $542.26.

Remove Ads

Insider Activity

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the business's stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the transaction, the insider now owns 124,243 shares of the company's stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,792 shares of company stock valued at $1,087,843. Company insiders own 5.70% of the company's stock.

Analyst Ratings Changes

Several research firms have recently issued reports on AXON. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Barclays reissued a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price target for the company. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Finally, JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.